Advertisement

Reduction in total patient isolation days with a change in influenza testing methodology

      Background

      Both hospital admissions and patient isolation increase during influenza season. Influenza testing methodologies that reduce turnaround time (TAT) could reduce time in isolation.

      Methods

      We assessed the impact of a new influenza test on TAT and isolation days. TAT and daily mean isolation days were compared at a single hospital over 2 influenza seasons. An automated real-time reverse-transcription polymerase chain reaction assay (rRT-PCR) with random access replaced a conventional rRT-PCR assay for the second influenza season. Automation and random access allowed continuous testing, rather than once daily testing 3-5 d/wk.

      Results

      Confirmed influenza cases (57 vs 68) and total patient days (66,308 vs. 66,366) were similar for the 2012-2013 and 2013-2014 influenza seasons. TAT fell from 35 to 3.6 hours. Daily mean isolation days (32.9 vs 27.7, P < .01) fell, as did days in contact precautions (25.0 vs 19.8, P < .01) and droplet precautions (6.0 vs 3.5, P < .01). Although daily mean droplet precaution days for confirmed influenza rose slightly (0.86 vs 1.1, P = .16), droplet precaution days for suspected influenza fell 85% (2.7 vs 0.41, P < .001).

      Conclusions

      Influenza testing technology that reduced TAT from days to hours resulted in a 42% reduction in droplet precaution days and reduced overall isolation days during influenza season.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Molinari N.A.
        • Ortega-Sanchez I.R.
        • Messonnier M.L.
        • Thompson W.W.
        • Wortley P.M.
        • Weintraub E.
        • et al.
        The annual impact of seasonal influenza in the US: measuring disease burden and costs.
        Vaccine. 2007; 25: 5086-5096
        • Simonsen L.
        • Fukuda K.
        • Schonberger L.B.
        • Cox N.J.
        The impact of influenza epidemics on hospitalizations.
        J Infect Dis. 2000; 181: 831-837
        • Thompson W.W.
        • Shay D.K.
        • Weintraub E.
        • Brammer L.
        • Bridges C.B.
        • Cox N.J.
        • et al.
        Influenza-associated hospitalizations in the United States.
        JAMA. 2004; 292: 1333-1340
        • Centers for Disease Control and Prevention (CDC)
        Prevention strategies for seasonal influenza in healthcare settings: guidelines and recommendations.
        (Available at) (Accessed April 20, 2016)
        • Morgan D.J.
        • Diekema D.J.
        • Sepkowitz K.
        • Perencevich E.N.
        Adverse outcomes associated with contact precautions: a review of the literature.
        Am J Infect Control. 2009; 37: 85-93
        • Morgan D.J.
        • Day H.R.
        • Harris A.D.
        • Furuno J.P.
        • Perencevich E.N.
        The impact of contact isolation on the quality of inpatient hospital care.
        PLoS ONE. 2011; 6: e22190